Please enable JavaScript to continue using this application.

Compare $IMUX vs $UNCY | Chartloom

Compare

$IMUX vs $UNCY

Immunic Inc · Unicycive Therapeutics Inc

IMUX

Immunic Inc

UNCY

Unicycive Therapeutics Inc

Compare $IMUX vs $UNCY

Comparing Immunic Inc and Unicycive Therapeutics Inc

IMUXImmunic Inc

UNCYUnicycive Therapeutics Inc

IMUXImmunic Inc

Market cap

$112M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

40.5%

52W performance

-8.8%

FCF yield

-78.9%

UNCYUnicycive Therapeutics Inc

Market cap

$110M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.31x

Rev growth (TTM)

—

YTD performance

-29.1%

52W performance

-13.8%

FCF yield

-25.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IMUX

UNCY

Detailed metrics comparison

IMUX

Immunic Inc

UNCY

Unicycive Therapeutics Inc

Market Cap

IMUX$112M

UNCY$110M

Enterprise Value

IMUX$-44M

UNCY$66M

Price

IMUX$8.19

UNCY$4.11

P/E Ratio

IMUXN/A

UNCYN/A

P/S Ratio

IMUX0.00x

UNCY31.15x

EV/Sales

IMUX0.00x

UNCY0.00x

EV/EBITDA

IMUX0.00x

UNCY0.00x

P/B Ratio

IMUX0.85x

UNCY2.21x

P/FCF Ratio

IMUXN/A

UNCYN/A

EV/FCF

IMUX0.49x

UNCY-2.35x

PEG Ratio

IMUXN/A

UNCYN/A

Forward P/E (NTM)

IMUXN/A

UNCYN/A

Forward P/S (NTM)

IMUXN/A

UNCY0.31x

Revenue (TTM)

IMUX$0

UNCY$0

Revenue Growth (YoY)

IMUXN/A

UNCYN/A

Forward Rev Growth

IMUX650.4%

UNCY37378.0%

Gross Margin (TTM)

IMUX0.0%

UNCY0.0%

Operating Margin (TTM)

IMUX0.0%

UNCY0.0%

EBITDA Margin (TTM)

IMUX0.0%

UNCY0.0%

Net Margin (TTM)

IMUX0.0%

UNCY0.0%

FCF Margin (TTM)

IMUXN/A

UNCYN/A

Net Income (TTM)

IMUX$-112M

UNCY$-35M

FCF (TTM)

IMUX$-88M

UNCY$-28M

EPS (TTM)

IMUX-$2.62

UNCY-$1.31

ROE (TTM)

IMUX-9567.0%

UNCY-8881.0%

ROA (TTM)

IMUX-10788.0%

UNCY-5966.0%

ROIC (TTM)

IMUX-9567.0%

UNCY-8881.0%

Cash

IMUX$155M

UNCY$44M

Debt

IMUX$0

UNCY$0

Net Cash/Debt

IMUX$155M

UNCY$44M

Current Ratio (TTM)

IMUX5.05x

UNCY3.81x

Quick Ratio (TTM)

IMUX5.00x

UNCY3.28x

Debt/Equity (TTM)

IMUX0.00x

UNCY0.00x

Debt/Assets (TTM)

IMUX0.0%

UNCY0.0%

Interest Coverage (TTM)

IMUXN/A

UNCYN/A

Net Debt/EBITDA (TTM)

IMUX0.00x

UNCY0.00x

Beta

IMUX1.47

UNCY1.78

52W Performance

IMUX-8.8%

UNCY-13.8%

YTD Performance

IMUX40.5%

UNCY-29.1%

% from 52W High

IMUX-53.0%

UNCY-53.0%

% from 52W Low

IMUX61.9%

UNCY4.6%

Asset Turnover (TTM)

IMUX0.00x

UNCY0.05x

FCF Yield (TTM)

IMUX-78.9%

UNCY-25.4%

Earnings Yield (TTM)

IMUX-100.0%

UNCY-32.1%

Dividend Yield (TTM)

IMUXN/A

UNCYN/A

Rule of 40

IMUX0.0

UNCY0.0

EV/GP/RG

IMUXN/A

UNCYN/A

Ticker research

View IMUX research View UNCY research

Metric	IMUX Immunic Inc	UNCY Unicycive Therapeutics Inc
Market & Valuation
Market Cap	$112M	$110M
Enterprise Value	$-44M	$66M
Price	$8.19	$4.11
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	31.15x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.85x	2.21x
P/FCF Ratio	N/A	N/A
EV/FCF	0.49x	-2.35x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	0.31x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	650.4%	37378.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-112M	$-35M
FCF (TTM)	$-88M	$-28M
EPS (TTM)	-$2.62	-$1.31
ROE (TTM)	-9567.0%	-8881.0%
ROA (TTM)	-10788.0%	-5966.0%
ROIC (TTM)	-9567.0%	-8881.0%
Financial Health
Cash	$155M	$44M
Debt	$0	$0
Net Cash/Debt	$155M	$44M
Current Ratio (TTM)	5.05x	3.81x
Quick Ratio (TTM)	5.00x	3.28x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.47	1.78
52W Performance	-8.8%	-13.8%
YTD Performance	40.5%	-29.1%
% from 52W High	-53.0%	-53.0%
% from 52W Low	61.9%	4.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.05x
FCF Yield (TTM)	-78.9%	-25.4%
Earnings Yield (TTM)	-100.0%	-32.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View IMUX research	View UNCY research

Valuation

P/S Ratio

IMUX

0.00x

UNCY

31.15x

EV/FCF

UNCY

-2.35x

IMUX

0.49x

Growth & revenue

Forward Revenue Growth

UNCY

37378.0%

IMUX

650.4%

Profitability & performance

Gross Margin

IMUX

0.0%

UNCY

0.0%

ROE

UNCY

-8881.0%

IMUX

-9567.0%

FCF Yield %

UNCY

-25.4%

IMUX

-78.9%

52-Week Performance

IMUX

-8.8%

UNCY

-13.8%

Detailed metrics comparison

IMUX

Immunic Inc

UNCY

Unicycive Therapeutics Inc

Market Cap

IMUX$112M

UNCY$110M

Enterprise Value

IMUX$-44M

UNCY$66M

Price

IMUX$8.19

UNCY$4.11

P/E Ratio

IMUXN/A

UNCYN/A

P/S Ratio

IMUX0.00x

UNCY31.15x

EV/Sales

IMUX0.00x

UNCY0.00x

EV/EBITDA

IMUX0.00x

UNCY0.00x

P/B Ratio

IMUX0.85x

UNCY2.21x

P/FCF Ratio

IMUXN/A

UNCYN/A

EV/FCF

IMUX0.49x

UNCY-2.35x

PEG Ratio

IMUXN/A

UNCYN/A

Forward P/E (NTM)

IMUXN/A

UNCYN/A

Forward P/S (NTM)

IMUXN/A

UNCY0.31x

Revenue (TTM)

IMUX$0

UNCY$0

Revenue Growth (YoY)

IMUXN/A

UNCYN/A

Forward Rev Growth

IMUX650.4%

UNCY37378.0%

Gross Margin (TTM)

IMUX0.0%

UNCY0.0%

Operating Margin (TTM)

IMUX0.0%

UNCY0.0%

EBITDA Margin (TTM)

IMUX0.0%

UNCY0.0%

Net Margin (TTM)

IMUX0.0%

UNCY0.0%

FCF Margin (TTM)

IMUXN/A

UNCYN/A

Net Income (TTM)

IMUX$-112M

UNCY$-35M

FCF (TTM)

IMUX$-88M

UNCY$-28M

EPS (TTM)

IMUX-$2.62

UNCY-$1.31

ROE (TTM)

IMUX-9567.0%

UNCY-8881.0%

ROA (TTM)

IMUX-10788.0%

UNCY-5966.0%

ROIC (TTM)

IMUX-9567.0%

UNCY-8881.0%

Cash

IMUX$155M

UNCY$44M

Debt

IMUX$0

UNCY$0

Net Cash/Debt

IMUX$155M

UNCY$44M

Current Ratio (TTM)

IMUX5.05x

UNCY3.81x

Quick Ratio (TTM)

IMUX5.00x

UNCY3.28x

Debt/Equity (TTM)

IMUX0.00x

UNCY0.00x

Debt/Assets (TTM)

IMUX0.0%

UNCY0.0%

Interest Coverage (TTM)

IMUXN/A

UNCYN/A

Net Debt/EBITDA (TTM)

IMUX0.00x

UNCY0.00x

Beta

IMUX1.47

UNCY1.78

52W Performance

IMUX-8.8%

UNCY-13.8%

YTD Performance

IMUX40.5%

UNCY-29.1%

% from 52W High

IMUX-53.0%

UNCY-53.0%

% from 52W Low

IMUX61.9%

UNCY4.6%

Asset Turnover (TTM)

IMUX0.00x

UNCY0.05x

FCF Yield (TTM)

IMUX-78.9%

UNCY-25.4%

Earnings Yield (TTM)

IMUX-100.0%

UNCY-32.1%

Dividend Yield (TTM)

IMUXN/A

UNCYN/A

Rule of 40

IMUX0.0

UNCY0.0

EV/GP/RG

IMUXN/A

UNCYN/A

Ticker research

View IMUX research View UNCY research

Metric	IMUX Immunic Inc	UNCY Unicycive Therapeutics Inc
Market & Valuation
Market Cap	$112M	$110M
Enterprise Value	$-44M	$66M
Price	$8.19	$4.11
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	31.15x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.85x	2.21x
P/FCF Ratio	N/A	N/A
EV/FCF	0.49x	-2.35x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	0.31x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	650.4%	37378.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-112M	$-35M
FCF (TTM)	$-88M	$-28M
EPS (TTM)	-$2.62	-$1.31
ROE (TTM)	-9567.0%	-8881.0%
ROA (TTM)	-10788.0%	-5966.0%
ROIC (TTM)	-9567.0%	-8881.0%
Financial Health
Cash	$155M	$44M
Debt	$0	$0
Net Cash/Debt	$155M	$44M
Current Ratio (TTM)	5.05x	3.81x
Quick Ratio (TTM)	5.00x	3.28x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.47	1.78
52W Performance	-8.8%	-13.8%
YTD Performance	40.5%	-29.1%
% from 52W High	-53.0%	-53.0%
% from 52W Low	61.9%	4.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.05x
FCF Yield (TTM)	-78.9%	-25.4%
Earnings Yield (TTM)	-100.0%	-32.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View IMUX research	View UNCY research